MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company offers branched aortic, thoracic, and bifurcated stent graft system; abdominal aortic stent graft and delivery system; and other stent graft system in surgical operation; as well as accessorie… Read more
MicroPort Endovascular MedTech Ltd - Asset Resilience Ratio
MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 24.62% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.17 Billion | 24.62% |
| Total Liquid Assets | CN¥1.17 Billion | 24.62% |
Asset Resilience Insights
- Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 24.62% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio
Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for MicroPort Endovascular MedTech Ltd (None–None)
The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||